Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Fusco, Giuliana ^a   De Simone, Alfonso ^b   Arosio, Paolo ^a   Vendruscolo, Michele ^a   Veglia, Gianluigi ^a   Dobson, Christopher M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN BINDING; SNCA PROTEIN, HUMAN;

BINDING SITE; CHEMISTRY; CONFORMATION; HUMAN; LIPID BILAYER; MEMBRANE; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE; SYNAPSE VESICLE;

ALPHA-SYNUCLEIN; BINDING SITES; HUMANS; LIPID BILAYERS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SYNAPTIC VESICLES;

EID: 84976448182     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27125     Document Type: Article

References (61)

1. Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953 (2012).
2. Dobson, C. M. Protein folding and misfolding. Nature 426, 884-890 (2003).
3. Uversky, V. N. & Eliezer, D. Biophysics of Parkinsons disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci 10, 483-499 (2009).
4. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75, 333-366 (2006).
5. Luth, E. S., Stavrovskaya, I. G., Bartels, T., Kristal, B. S. & Selkoe, D. J. Soluble, prefibrillar alpha-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction. J Biol Chem 289, 21490-21507 (2014).
6. Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat Rev Neurol 9, 13-24 (2013).
7. Bosco, D. A. et al. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol 2, 249-253 (2006).
8. Ikenoue, T. et al. Cold denaturation of alpha-synuclein amyloid fibrils. Angew Chem Int Ed Engl 53, 7799-7804 (2014).
9. Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45-51 (2013).
10. Paslawski, W., Mysling, S., Thomsen, K., Jorgensen, T. J. & Otzen, D. E. Co-existence of two different alpha-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry. Angew Chem Int Ed Engl 53, 7560-7563 (2014).
11. Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinsons disease. Science 276, 2045-2047 (1997).
12. Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinsons disease. Science 302, 841 (2003).
13. Barbour, R. et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5, 55-59 (2008).
14. Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8, 2804-2815 (1988).
15. Auluck, P. K., Caraveo, G. & Lindquist, S. alpha-Synuclein: membrane interactions and toxicity in Parkinsons disease. Annu Rev Cell Dev Biol 26, 211-233 (2010).
16. Cooper, A. A. et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinsons models. Science 313, 324-328 (2006).
17. Vargas, K. J. et al. Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci 34, 9364-9376 (2014).
18. Soper, J. H. et al. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol Biol Cell 19, 1093-1103 (2008).
19. Maltsev, A. S., Ying, J. & Bax, A. Impact of N-Terminal acetylation of alpha-synuclein on its random coil and lipid binding properties. Biochemistry 51, 5004-5013 (2012).
20. Bodner, C. R., Dobson, C. M. & Bax, A. Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J Mol Biol 390, 775-790 (2009).
21. Snead, D. & Eliezer, D. Alpha-synuclein function and dysfunction on cellular membranes. Exp Neurobiol 23, 292-313 (2014).
22. Lee, H. J., Choi, C. & Lee, S. J. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277, 671-678 (2002).
23. Galvagnion, C. et al. Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation. Nat Chem Biol 11, 229-234 (2015).
24. Dedmon, M. M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M. & Dobson, C. M. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc 127, 476-477 (2005).
25. Fusco, G. et al. Direct observation of the three regions in alpha-synuclein that determine its membrane-bound behaviour. Nat Commun 5, 3827 (2014).
26. Bodner, C. R., Maltsev, A. S., Dobson, C. M. & Bax, A. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinsons disease revealed by solution NMR spectroscopy. Biochemistry 49, 862-871 (2010).
27. Maltsev, A. S., Chen, J., Levine, R. L. & Bax, A. Site-specific interaction between alpha-synuclein and membranes probed by NMRobserved methionine oxidation rates. J Am Chem Soc 135, 2943-2946 (2013).
28. Wang, G. F., Li, C. & Pielak, G. J. 19F NMR studies of alpha-synuclein-membrane interactions. Protein Sci 19, 1686-1691 (2010).
29. Ulmer, T. S., Bax, A., Cole, N. B. & Nussbaum, R. L. Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem 280, 9595-9603 (2005).
30. Lokappa, S. B. & Ulmer, T. S. Alpha-synuclein populates both elongated and broken helix states on small unilamellar vesicles. J Biol Chem 286, 21450-21457 (2011).
31. Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S. & Langen, R. Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci USA 105, 19666-19671 (2008).
32. Bartels, T. et al. The N-Terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding. Biophys J 99, 2116-2124 (2010).
33. Kohlhoff, K. J., Robustelli, P., Cavalli, A., Salvatella, X. & Vendruscolo, M. Fast and accurate predictions of protein NMR chemical shifts from interatomic distances. J Am Chem Soc 131, 13894-13895 (2009).
34. Robustelli, P., Kohlhoff, K., Cavalli, A. & Vendruscolo, M. Using NMR chemical shifts as structural restraints in molecular dynamics simulations of proteins. Structure 18, 923-933 (2010).
35. Krieger, J. M. et al. Conformational recognition of an intrinsically disordered protein. Biophys J 106, 1771-1779 (2014).
36. Shen, Y. & Bax, A. SPARTA+ : A modest improvement in empirical NMR chemical shift prediction by means of an artificial neural network. J Biomol NMR 48, 13-22 (2010).
37. Camilloni, C., De Simone, A., Vranken, W. F. & Vendruscolo, M. Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry 51, 2224-2231 (2012).
38. Wang, C., Shah, N., Thakur, G., Zhou, F. & Leblanc, R. M. Alpha-synuclein in alpha-helical conformation at air-water interface: implication of conformation and orientation changes during its accumulation/aggregation. Chem Commun (Camb) 46, 6702-6704 (2010).
39. De Simone, A., Mote, K. R. & Veglia, G. Structural dynamics and conformational equilibria of SERCA regulatory proteins in membranes by solid-state NMR restrained simulations. Biophys J 106, 2566-2576 (2014).
40. Magzoub, M., Eriksson, L. E. & Graslund, A. Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: effects of surface charge and peptide concentration. Biochim Biophys Acta 1563, 53-63 (2002).
41. Zhang, Y. et al. Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formation. ACS Chem Biol 10, 1082-1093 (2015).
42. Ashworth Briggs, E. L. et al. Interaction between the NS4B amphipathic helix, AH2, and charged lipid headgroups alters membrane morphology and AH2 oligomeric state-implications for the hepatitis C virus life cycle. Biochim Biophys Acta 1848, 1671-1677 (2015).
43. Gustavsson, M. et al. Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban. Proc Natl Acad Sci USA 110, 17338-17343 (2013).
44. Vicari, C. et al. Artificial heme-proteins: determination of axial ligand orientations through paramagnetic NMR shifts. Chem Commun (Camb) 50, 3852-3855 (2014).
45. Vamvaca, K., Volles, M. J. & Lansbury, P. T., Jr. The first N-Terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast. J Mol Biol 389, 413-424 (2009).
46. Gitler, A. D. et al. The Parkinsons disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA 105, 145-150 (2008).
47. Diao, J. et al. Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2. Elife 2, e00592 (2013).
48. Nemani, V. M. et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79 (2010).
49. Wislet-Gendebien, S. et al. Cytosolic proteins regulate alpha-synuclein dissociation from presynaptic membranes. J Biol Chem 281, 32148-32155 (2006).
50. Cookson, M. R. The biochemistry of Parkinsons disease. Annu Rev Biochem 74, 29-52 (2005).
51. Rodriguez, J. A. et al. Structure of the toxic core of alpha-synuclein from invisible crystals. Nature 525, 486-490 (2015).
52. Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein. Nat Struct Mol Biol, 23, 409-15 (2016).
53. Takegoshi, K. & Terao, T. 13C-1H dipolar recoupling under very fast magic-Angle spinning using virtual pulses. Solid State Nucl Magn Reson 13, 203-212 (1999).
54. Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theor Comput 4, 435-447 (2008).
55. Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950-1958 (2010).
56. Horn, H. W. et al. Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew. J Chem Phys 120, 9665-9678 (2004).
57. Jambeck, J. P. & Lyubartsev, A. P. Derivation and systematic validation of a refined all-Atom force field for phosphatidylcholine lipids. J Phys Chem B 116, 3164-3179 (2012).
58. Hess, B., Bekker, H., Berendsen, H. W. & Fraaije, J. G. LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18, 1463-1472 (1997).
59. Darden, T., Perera, L., Li, L. & Pedersen, L. New tricks for modelers from the crystallography toolkit: The particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure 7, R55-60 (1999).
60. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J Chem Phys 126, 014101 (2007).
61. Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637 (1983).